Skip to NavigationSkip to content

GW Pharma appoints president and moves CEO to US

Published on: 22/05/15

US biopharma firm GW Pharmaceuticals has appointed Julian Gangolli as president of its North American division, and is also relocating its chief executive Justin Gover to the US.

Gangolli (pictured) was the president of the North American pharma division of Allergan from 2004 until April this year, and was a corporate VP and member of its executive committee there.

Gangolli joins GW in June and is also expected to be appointed to the company’s board of directors.

Gangolli says: “I wish to bring my experience of building a successful business for Allergan to GW and look forward to working with Justin and the entire GW team to optimise the company’s prospects in this key market.”

GW will locate its US operation in Southern California where Gangolli and Gover will be based. 

Dr Geoffrey Guy who is GW’s chairman, adds: “Julian’s deep experience at building and running a major US pharmaceutical business built on speciality products will be complemented by the relocation of Justin to the US with his intimate knowledge of GW, its products and pipeline. 

“Together, they will spearhead GW’s growth in the US and help to bring much needed new treatments to patients.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches